Request Demo
Last update 16 May 2025
TQB-2223/Penpulimab
Last update 16 May 2025
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms TQB2223/Penpulimab, TQB2252 |
Target |
Action inhibitors |
Mechanism LAG3 inhibitors(Lymphocyte activation gene 3 protein inhibitors), PD-1 inhibitors(Programmed cell death protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 616719118L
The sequence is quoted from: *****
Sequence Code 616722917H
The sequence is quoted from: *****
Related
2
Clinical Trials associated with TQB-2223/PenpulimabCTR20243867
评估TQB2252注射液在晚期恶性肿瘤受试者中安全性和药代动力学的多中心、开放的I期临床试验
[Translation] A multicenter, open-label Phase I clinical trial to evaluate the safety and pharmacokinetics of TQB2252 injection in subjects with advanced malignant tumors
NCT06649656
A Multicenter, Open Label Phase I Clinical Trial Evaluating the Safety and Pharmacokinetics of TQB2252 Injection in Subjects With Advanced Malignant Tumors
100 Clinical Results associated with TQB-2223/Penpulimab
Login to view more data
100 Translational Medicine associated with TQB-2223/Penpulimab
Login to view more data
100 Patents (Medical) associated with TQB-2223/Penpulimab
Login to view more data
100 Deals associated with TQB-2223/Penpulimab
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 18 Nov 2024 | |
| Advanced cancer | Phase 1 | China | 01 Nov 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free